Pharma manufacturing refers to the industrial production of pharmaceutical drugs, involving synthesis, preparation, and packaging, while adhering to stringent regulatory standards for safety and quality. The process spans from research and development and raw material procurement to formulation, mixing, and final packaging, with critical quality control throughout. Globally, the sector is innovating with predictive approaches, data-driven discovery, continuous manufacturing, 3D printing, mRNA technology, and a strong focus on sustainability. Digital technologies and AI are crucial for real-time monitoring and waste reduction, moving towards personalized medicine. In Saudi Arabia, it's a growing sector aiming for drug security, with a market size of 30 billion SAR and approximately 40 factories covering 36% of local needs. Key players include Saudi Pharmaceutical Industries (SPI) and MS Pharma Saudi, with oversight by the SFDA.
